Nikolas Blevins, MD
Otolaryngology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 2 carriers
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
5 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Blevins’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G68567 · Current
Licensed to practise in California · since 2003 · expires 2027-02-28 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$69,873
Medicare paid this office $69,873 for 280 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Insertion of cochlear device | 14 | $15,810 | $1,129 |
| Short return visit (20+ min) | 156 | $12,851 | $56 |
| New patient visit (45+ min) | 76 | $8,283 | $109 |
| Return visit (30+ min) | 62 | $5,303 | $79 |
| Exam of ear using a microscope | 21 | $190 | $7 |
Who their Medicare patients are
280 Original Medicare patients in 2024. Average age 75 · Under 65 8% · 85 and older 15% · Women 52% · Also on Medicaid 11% · Health risk score 1.07. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 66% · Coronary heart disease 24% · Diabetes 23% · Chronic kidney disease 20% · Atrial fibrillation 16% · Cancer 15% · Depression 15% · COPD 10% · Heart failure 9% · Stroke 9% · Dementia 4%.
The office billed $446,598, Medicare allowed $92,048 and paid $69,873; for 490 services of 39 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 280 | 490 | 75 | 1.07 | $446,598 | $69,873 |
| 2023 | 232 | 390 | 75 | 0.97 | $330,433 | $61,820 |
| 2022 | 218 | 403 | 75 | 0.97 | $397,734 | $62,207 |
| 2021 | 248 | 463 | 73 | 0.95 | $372,953 | $66,769 |
| 2020 | 219 | 451 | 74 | 1.07 | $359,848 | $60,187 |
| 2019 | 245 | 470 | 73 | 1.05 | $428,638 | $73,341 |
| 2018 | 212 | 392 | 72 | 1.05 | $492,573 | $77,615 |
| 2017 | 258 | 483 | 72 | 1.22 | $545,968 | $89,465 |
| 2016 | 261 | 511 | 72 | 1.02 | $449,008 | $77,380 |
| 2015 | 263 | 548 | 72 | 1.05 | $562,437 | $90,990 |
| 2014 | 297 | 555 | 72 | 1.06 | $468,836 | $79,845 |
| 2013 | 288 | 537 | 71 | 1.14 | $446,569 | $78,786 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Insertion of cochlear device | 19 | $21,284 | $1,120 |
| Short return visit (20+ min) | 124 | $9,051 | $55 |
| New patient visit (45+ min) | 63 | $6,487 | $103 |
| Return visit (30+ min) | 50 | $4,065 | $78 |
| New patient visit (30+ min) | 13 | $909 | $70 |
| Exam of ear using a microscope | 25 | $268 | $7 |
2022: 5 services
| Insertion of cochlear device | 17 | $21,706 | $1,206 |
| Short return visit (20+ min) | 125 | $9,865 | $56 |
| New patient visit (45+ min) | 43 | $4,996 | $116 |
| Return visit (30+ min) | 42 | $3,685 | $88 |
| Exam of ear using a microscope | 42 | $456 | $8 |
2021: 6 services
| Insertion of cochlear device | 18 | $19,739 | $1,097 |
| Short return visit (20+ min) | 125 | $9,667 | $52 |
| New patient visit (45+ min) | 66 | $7,177 | $109 |
| Return visit (30+ min) | 59 | $5,225 | $78 |
| New patient visit (30+ min) | 14 | $928 | $66 |
| Exam of ear using a microscope | 48 | $431 | $7 |
2020: 6 services
| Insertion of cochlear device | 18 | $22,273 | $1,237 |
| Short return visit (20+ min) | 118 | $8,322 | $44 |
| New patient visit (45+ min) | 44 | $4,917 | $112 |
| Return visit (30+ min) | 47 | $3,209 | $65 |
| New patient visit (30+ min) | 20 | $1,258 | $63 |
| Exam of ear using a microscope | 38 | $600 | $9 |
2019: 7 services
| Insertion of cochlear device | 23 | $26,108 | $1,135 |
| Short return visit (20+ min) | 111 | $6,927 | $41 |
| Return visit (30+ min) | 64 | $4,500 | $64 |
| New patient visit (45+ min) | 42 | $4,255 | $101 |
| New patient visit (30+ min) | 23 | $1,303 | $57 |
| New patient visit (15+ min) | 12 | $507 | $42 |
| Exam of ear using a microscope | 43 | $499 | $8 |
2018: 6 services
| Insertion of cochlear device | 23 | $25,721 | $1,118 |
| Short return visit (20+ min) | 99 | $5,578 | $43 |
| New patient visit (45+ min) | 49 | $5,251 | $107 |
| Return visit (30+ min) | 43 | $2,967 | $67 |
| New patient visit (30+ min) | 11 | $748 | $68 |
| Exam of ear using a microscope | 52 | $494 | $8 |
2017: 6 services
| Insertion of cochlear device | 31 | $34,414 | $1,110 |
| New patient visit (45+ min) | 66 | $7,158 | $108 |
| Short return visit (20+ min) | 94 | $5,487 | $39 |
| Return visit (30+ min) | 76 | $5,311 | $66 |
| New patient visit (30+ min) | 19 | $1,152 | $61 |
| Exam of ear using a microscope | 59 | $564 | $7 |
2016: 6 services
| Insertion of cochlear device | 23 | $26,270 | $1,142 |
| New patient visit (45+ min) | 80 | $8,591 | $107 |
| Short return visit (20+ min) | 101 | $5,794 | $36 |
| Return visit (30+ min) | 65 | $4,413 | $67 |
| New patient visit (30+ min) | 27 | $1,421 | $53 |
| Exam of ear using a microscope | 62 | $738 | $8 |
2015: 6 services
| Insertion of cochlear device | 16 | $17,052 | $1,066 |
| Short return visit (20+ min) | 144 | $8,529 | $41 |
| New patient visit (45+ min) | 38 | $4,035 | $106 |
| New patient visit (30+ min) | 61 | $4,010 | $66 |
| Return visit (30+ min) | 28 | $1,611 | $52 |
| Exam of ear using a microscope | 55 | $785 | $8 |
2014: 6 services
| Insertion of cochlear device | 23 | $25,849 | $1,124 |
| Short return visit (20+ min) | 152 | $8,982 | $39 |
| New patient visit (45+ min) | 69 | $7,907 | $115 |
| Return visit (30+ min) | 45 | $3,146 | $68 |
| New patient visit (30+ min) | 39 | $2,142 | $55 |
| Exam of ear using a microscope | 53 | $629 | $8 |
2013: 6 services
| Insertion of cochlear device | 21 | $23,383 | $1,113 |
| Short return visit (20+ min) | 185 | $9,423 | $37 |
| New patient visit (45+ min) | 47 | $4,992 | $106 |
| New patient visit (30+ min) | 62 | $3,825 | $62 |
| Return visit (30+ min) | 15 | $918 | $57 |
| Exam of ear using a microscope | 45 | $514 | $8 |
Drugs they prescribed that Part D paid
$3,408
Pharmacies billed $3,408 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
58 generic and 14 brand-name prescriptions · $3,408 in drug cost · 16 antibiotic prescriptions to 15 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ciprofloxacin-Dexamethasone | 12 | $1,422 | $118 |
| Ofloxacin | 13 | $655 | $50 |
Year by year
| 2024 | 72 | 34 | None | 19% | $3,408 |
| 2023 | 44 | 26 | None | None | $1,584 |
| 2022 | 52 | 26 | None | 21% | $4,115 |
| 2021 | 52 | 25 | None | None | $7,782 |
| 2020 | 63 | 28 | None | 24% | $4,280 |
| 2019 | 57 | 30 | None | None | $3,248 |
| 2018 | 73 | 36 | None | 15% | $4,520 |
| 2017 | 85 | 48 | None | 19% | $5,262 |
| 2016 | 95 | 42 | None | 37% | $8,248 |
| 2015 | 189 | 71 | 6% (12) | 34% | $22,891 |
| 2014 | 129 | 65 | 14% (18) | None | $5,620 |
| 2013 | 156 | 61 | 10% (15) | 28% | $8,654 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2019: 1 drug
| Cephalexin | 11 | $122 | $11 |
2017: 3 drugs
| Ciprodex | 13 | $2,617 | $201 |
| Ofloxacin | 24 | $1,528 | $64 |
| Cephalexin | 12 | $64 | $5 |
2016: 1 drug
| Ciprodex | 21 | $4,323 | $206 |
2015: 3 drugs
| Ciprodex | 45 | $7,964 | $177 |
| Ofloxacin | 21 | $1,391 | $66 |
| Cephalexin | 18 | $92 | $5 |
2014: 4 drugs
| Ciprodex | 11 | $1,898 | $173 |
| Ofloxacin | 13 | $374 | $29 |
| Hydrocodone-Acetaminophen | 17 | $130 | $8 |
| Cephalexin | 22 | $110 | $5 |
2013: 5 drugs
| Ciprodex | 26 | $4,174 | $161 |
| Acetazolamide | 14 | $829 | $59 |
| Ofloxacin | 17 | $312 | $18 |
| Cephalexin | 19 | $120 | $6 |
| Hydrocodone-Acetaminophen | 15 | $89 | $6 |
Money from drug and device companies
$192 in 2025
| 2025 | 1 | 10 | None | $192 |
| 2023 | 1 | 1 | None | $25 |
| 2021 | 1 | 2 | None | $81 |
| 2019 | 1 | 2 | None | $6,038 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Midas Rex | $192 | 10 payments
|
See all 10 published payments
| Medtronic | Meals · 2025-04-06 | Midas Rex | $11 |
| Medtronic | Meals · 2025-04-06 | Midas Rex | $2 |
| Medtronic | Meals · 2025-04-06 | Midas Rex | $42 |
| Medtronic | Meals · 2025-04-06 | Midas Rex | $45 |
| Medtronic | Meals · 2025-04-06 | Midas Rex | $2 |
| Medtronic | Meals · 2025-04-05 | Midas Rex | $12 |
| Medtronic | Meals · 2025-04-05 | Midas Rex | $30 |
| Medtronic | Meals · 2025-04-05 | Midas Rex | $2 |
| Medtronic | Meals · 2025-04-05 | Midas Rex | $35 |
| Medtronic | Meals · 2025-04-05 | Midas Rex | $10 |
See earlier years (2023, 2021, 2019)
2023: $25
| iotaMotion | Iotasoft Insertion System | $25 | 1 payment
|
2021: $81
| Stryker | N/A | $81 | 2 payments
|
2019: $6,038
| Med-El | Med-El Maestro Cochlear Implant System | $6,038 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1093863169
- Licence
- CA 6068567, CA G68567California G68567: Current · expires 2027-02-28
- Trained
- Harvard Medical School, 1988
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207YX0901X (207YX0901X); Otolaryngology (207Y00000X)
- Mailing address
- 801 Welch Rd, Stanford, CA, 94305
- NPI first listed
- 2007-01-08
- NPI last updated
- 2024-04-28
- NPI record certified
- 2024-04-28
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 801 Welch Rd, Stanford, CA, 94305